Target intelligence / Profile preview

14-3-3 protein family (14-3-3)

Target
14-3-3
Molecular classification
Adapter protein, Scaffolding protein, Molecular chaperone
01

Overview

14-3-3 proteins are a family of highly conserved regulatory adapter proteins that play a central role in cellular signaling by binding to a diverse range of phosphorylated client proteins (UniProt: P63104). These proteins, which include seven human isoforms (beta, gamma, epsilon, eta, sigma, theta, and zeta), function as molecular scaffolds that modulate the activity, subcellular localization, and stability of their binding partners (PMID: 30555144). By interacting with over 200 different clients, such as kinases, phosphatases, and transcription factors, 14-3-3 proteins regulate critical biological processes including the cell cycle, apoptosis, and signal transduction (Wikipedia: 14-3-3 protein). In many diseases, particularly cancer and neurodegeneration, the expression or interaction patterns of 14-3-3 proteins are significantly altered, contributing to pathological signaling (PMID: 29133758). Consequently, 14-3-3 proteins have emerged as attractive therapeutic targets, with drug development efforts focusing on small-molecule inhibitors or stabilizers that can specifically modulate protein-protein interactions to achieve therapeutic effects (PMID: 31430110).

Other names
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation proteinYWHA family14-3-3 proteins14-3-3 adapter proteins
02

Mechanism of action

Modulation of protein-protein interactions (PPIs) by either inhibiting the binding of 14-3-3 to its client proteins or stabilizing the 14-3-3/client complex to alter downstream signaling pathways (PMID: 31430110).

03

Biological functions

Signal transductionCell cycle regulationApoptosisProtein traffickingMetabolic regulationProtein folding and stability
04

Disease associations

CancerNeurodegenerative disease (e.g., Alzheimer's, Parkinson's)Cardiovascular diseaseCreutzfeldt-Jakob diseaseInflammation
05

Safety considerations

Ubiquitous expression across almost all tissues leading to potential systemic toxicity (PMID: 30555144)Complexity of the 14-3-3 interactome making specific targeting difficultRisk of disrupting essential homeostatic signaling pathways (PMID: 29133758)
06

Interacting drugs

Fusicoccin (stabilizer) (PMID: 23839144)

6 more in the full profile.

07

Biomarkers

14-3-3 protein in cerebrospinal fluid (CSF) for Creutzfeldt-Jakob disease (PMID: 22431478)YWHAZ (14-3-3 zeta) expression levels in solid tumors (PMID: 29133758)SFN (14-3-3 sigma) methylation status in cancer (PMID: 11507054)

Beyond the preview

Go deeper on 14-3-3 protein family (14-3-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 14-3-3 protein family (14-3-3).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call